NS
Nallabotu Sarat Chandra Kumar
About Nallabotu Sarat Chandra Kumar
Data last updated:
Nallabotu Sarat Chandra Kumar has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Jalks Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Jalks Pharmaceuticals Private Limited at ₹2.91 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Jalks Pharmaceuticals Private Limited U74999TN2018PTC121411 | Director | 14 Mar 2018 | 2018 | ₹2.91 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nallabotu Sarat Chandra Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nallabotu Sarat Chandra Kumar
Nallabotu Sarat Chandra Kumar has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Jalks Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Jalks Pharmaceuticals Private Limited at ₹2.91 Cr (FY 2024).
Nallabotu Sarat Chandra Kumar is associated with 1 company as Director, including Jalks Pharmaceuticals Private Limited (₹2.91 Cr).
Nallabotu Sarat Chandra Kumar has expertise in General Business.
Nallabotu Sarat Chandra Kumar has 8 years in corporate governance.
By reported revenue, the largest current company of Nallabotu Sarat Chandra Kumar is Jalks Pharmaceuticals Private Limited, with revenue of ₹2.91 Cr (FY 2024).
Nallabotu Sarat Chandra Kumar currently holds positions at 1 company: Jalks Pharmaceuticals Private Limited (₹2.91 Cr).